Handelsavisen
prelaunch
Companies Healthcare AOTI.L
AO
AOTI.L London Stock Exchange Medical Equipment, Supplies & Distribution

Aoti.L

$57,50
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
8,3 %
ROE
13,4 %
Net margin
4,0 %
Debt / equity
1,00
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

AOTI.L provides medical equipment, supplies, and distribution services within the healthcare sector.

Business. AOTI.L provides medical equipment, supplies, and distribution services within the healthcare sector.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
BUY2 analysts
2 buy0 hold0 sell
Avg 12m price target91,00

Analyst recommendations

2 analysts · consensus Buy
Buy2
Hold0
Sell0
12-month price target
91,00
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
2 analysts · indicative
Ownership
not yet wired
Profitability
13,4 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning AOTI.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to AOTI.L. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    AOTI.L provides medical equipment, supplies, and distribution services within the healthcare sector.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    AOTI.L has a liquidity profile that is characterized by a current ratio of 3.11, indicating a strong ability to meet short-term obligations with its current assets. However, the company's cash and equivalents of $13.44 million are offset by long-term debt of $19.86 million, resulting in a net cash position that is negative. This suggests a potential liquidity risk despite the high current ratio.

    In terms of profitability, AOTI.L reports a return on equity (ROE) of 13.37% and a return on assets (ROA) of 4.79%. These figures suggest that the company is generating a reasonable return for its shareholders and effectively utilizing its assets. However, the operating income of $5.53 million and net income of $2.67 million indicate that the company's profitability is modest relative to its revenue of $66.54 million.

    The company's revenue is primarily derived from its operations in the medical equipment, supplies, and distribution sector. While the input data does not provide specific segment or geographic breakdowns, the company's exposure is concentrated within the healthcare services and equipment industry. This concentration may pose a risk if the industry faces regulatory or economic headwinds.

    Looking at the growth trajectory, AOTI.L has a free cash flow of $3.02 million and a capital expenditure of -$1.81 million. These figures suggest that the company is generating positive cash flow from operations and is not heavily investing in new capital projects. The company's growth is likely to be driven by its ability to maintain and expand its existing operations rather than through significant capital investments.

    The risk assessment for AOTI.L indicates a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio of 1.0 suggests a balanced capital structure, but the negative net cash position after subtracting total debt is a key flag. The company's dilution risk is low, which is a positive sign for shareholders. However, the company should monitor its liquidity to ensure it can meet its obligations.

    Recent events and filings for AOTI.L include analyst estimates that suggest a strong buy recommendation with a mean price target of $91.00 and a median price target of $91.00. The high price target is $108.00, while the low is $74.00. The mean recommendation of 1.00 indicates a strong buy consensus among analysts. These estimates suggest that the market has a positive outlook on the company's future performance.

    Key takeaways
    • AOTI.L has a strong current ratio of 3.11, indicating a solid short-term liquidity position.
    • The company's ROE of 13.37% and ROA of 4.79% suggest reasonable profitability and asset utilization.
    • AOTI.L's revenue is concentrated in the medical equipment, supplies, and distribution sector, which may pose a risk if the industry faces challenges.
    • The company's free cash flow of $3.02 million and capital expenditure of -$1.81 million indicate a focus on maintaining existing operations rather than significant capital investments.
    • Analysts have a strong buy consensus for AOTI.L, with a mean price target of $91.00.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $57,50
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $19.9M
    Net cash
    -$6.4M
    Current ratio
    3.1
    Debt / equity
    1.0
    ROA
    4.8%
    ROE
    13.4%
    Cash conversion
    -180.0%
    CapEx / revenue
    -2.7%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    0,02
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    2
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-10 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate0,02
    Revenueno estimateno estimate66,2M USD
    Operating incomeno estimateno estimate5,7M USD
    Full-year consensus mean (period as reported by source) · consensus in USD. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution2 analysts
    Strong buy2
    Buy0
    Hold0
    Sell0
    Strong sell0
    12-month price target$91,00 · Median $91,00
    Low $74,00High $108,00
    Operating income · consensus5,7M USD
    EPS surprise
    −99,2 %
    reported vs consensus · miss
    Revenue surprise
    +0,5 %
    reported vs consensus · beat

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$74,00
    Mean$91,00
    Median$91,00
    High$108,00
    Spot$57,50
    +58.3 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin8,3 %Above median
    Net Margin4,0 %Above median
    ROE13,4 %Above P75
    Capex / Rev-2,7 %Above median
    D/E1,00Bottom quartile
    Cash Conv-1,80Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • AOTI.L Market data — financials · 2026-05-27
    • Aoti Inc Market data — analyst estimates · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    AOTI.LCanonical
    London Stock Exchange · USD

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage